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W.J. Schwaeble2Departments of 1Cardiovascular Sciences, 2Infection, Immunity and Inflammation, and 3Health Sciences,
University of Leicester, Leicester, UKObjective. Patients undergoing abdominal aortic aneurysm (AAA) repair are exposed to an ischaemia-reperfusion injury
(IRI), which is in part mediated by complement activation. We investigated the role of the novel lectin pathway of
complement during IRI in patients undergoing AAA repair.
Methods. Patients undergoing elective open infrarenal AAA repair had systemic blood samples taken at induction of
anaesthesia, prior to aortic clamping, prior to aortic declamping and at reperfusion. Control patients undergoing major
abdominal surgery were also included. Plasma was assayed for levels of mannan-binding lectin (MBL) using ELISA
techniques. Consumption of plasma MBL was used as a measure of lectin pathway activation.
Results. Twenty-three patients undergoing AAA repair and eight control patients were recruited. No lectin pathway
activation could be demonstrated in the control patients. AAA patients experienced a mean decrease in plasma MBL levels of
41% representing significant lectin pathway activation (pZ0.003).
Conclusion. Consumption of MBL occurs during AAA repair, suggesting an important role for the lectin pathway in IRI.
Specific transient inhibition of lectin pathway activity could be of significant therapeutic value in patients undergoing open
surgical AAA repair.Keywords: Aortic aneurysm, Abdominal; Mannan-binding lectin; Reperfusion injury.Introduction
Abdominal aortic aneurysm (AAA) repair is associated
with an inflammatory response,1 which is thought in
part to originate as a result of an ischaemia-reperfusion
injury (IRI), secondary to aortic clamping. This response
is mediated via several pathways, resulting in the
production of a number of components of the inflam-
matory response including cytokines,2 lipid-derived
mediators3 and complement components.4 Excessive
inflammation can lead to systemic effects (the systemic
inflammatory response syndrome or SIRS),5 and if
severe may progress to organ failure.6 Once established,
organ failure has an appreciable mortality.7
Activation of the complement system has been
demonstrated to occur as a result of IRI, and has
specifically been demonstrated to occur during AAA
repair.4,8–10 The complement system may be activateding author. Michael G.A. Norwood, MRCS, MD
llow), Department of Vascular Surgery, Robert Kilpa-
Sciences Building, Leicester Royal Infirmary, Leicester
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tive pathway and the lectin pathway. The lectin
pathway is activated when specific recognition
complexes (comprising either MBL, H-ficolin or
L-ficolin, complexed with the MBL-associated serine
proteases 1–3) bind to effector molecules.11 These
effector molecules (cell surface carbohydrate ligands)
were originally detected on bacterial cell walls, and the
lectin pathway has been demonstrated to be important
in defence against infection. More recently however,
activation of the lectin pathway has been demon-
strated to occur on contact with ischaemic endothelial
cells. Activation of the lectin pathway is accompanied
by consumption of all components involved, including
the initiating recognition complexes.
Traditionally, the classical pathway has been
assumed responsible for IRI-mediated complement
activation.12 However, recent research using murine
models of IRI indicates that the lectin pathway is also
activated during IRI.13 The aim of this study was to
investigate whether consumption of lectin pathway
activation complexes occurs in patients undergoing
AAA repair.Eur J Vasc Endovasc Surg 31, 239–243 (2006)
doi:10.1016/j.ejvs.2005.09.012, available online at http://www.sciencedirect.com onved.
Table 1. Demographic data for all AAA subjects and controls
AAA patients
(nZ23)
Controls (nZ8)
Mean age (S.D.) 67.74 (6.17) 54.75 (10.63)
Sex _Z20 (87%) _Z4 (50%)
Smoking history YesZ9 (39.1%) YesZ3 (37.5%)
ExZ12 (52.2%) Ex Z1 (12.5%)
NonZ2 (8.7%) NoZ4 (50%)
Hypertension 16 (69.6%) 3 (37.5%)
Ischaemic heart disease 8 (34.8%) 1 (12.5%)
Peripheral vascular
disease
4 (17.4%) 0
Cerebrovascular disease 3 (13.0%) 0
Diabetes 4 (17.4%) 1 (12.5%)
Results are displayed as the number of patients, with percentage
values given in brackets.
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Consecutive patients undergoing elective, transper-
itoneal repair of infrarenal AAA were recruited.
Ethical approval was granted by the local Ethics
Committee. All patients gave informed consent, and
all procedures were followed in accordance with
institutional guidelines. Subjects that were MBL-
deficient (serum MBL!50 ng/ml) were excluded
from this study. Arterial blood samples were taken
from a radial artery line, which was sited at the time of
induction of anaesthesia. Blood samples were taken at
four defined time points during the procedure (time
point 1: induction of anaesthesia, time point 2: just
prior to aortic clamping, time point 3: just prior to
aortic clamp removal and time point 4: after 30 min of
reperfusion). Samples were taken using a sterile
syringe, and the blood was transferred to 7 ml sterile
glass EDTA tubes (Becton Dickinson, UK) and
immediately placed on ice until the end of the
operation, when samples were centrifuged at 2220 g
for 10 min at 4 8C. Plasma was snap frozen for
subsequent batch analysis. For comparison, control
patients undergoing surgery to the pancreas and
biliary tree were also recruited. Control patients had
radial artery blood taken at two defined time points
during the procedure (time point 1: induction of
anaesthesia, time point 2: 2 h after the start of the
procedure). Time point 2 corresponded with the
reperfusion sample (time point 4) from AAA patients.
MBL levels were quantified using a modification of
the method described by Haurum et al.13 Briefly; Nunc
Maxisorb microtiter plates (Nalge Nunc International,
Rochester, NY) were coated with 1 mg/well of mannan
(Sigma-Aldrich, St Louis, MO) in 15 mM Na2CO3,
35 mM NaHCO3, pH 9.6. Wells were blocked with
0.1% HSA in TBS (10 mM Tris–Cl, 140 mM NaCl, pH
7.4), then washed with TBS containing 0.05% Tween 20
and 5 mM CaCl2 (wash buffer). Serum samples were
diluted in 20 mM Tris–Cl, 1 M NaCl, 10 mM CaCl2,
0.05% Triton X-100, 0.1% HSA, pH 7.4, added to the
plates and incubated overnight at 4 8C. After washing,
bound MBL was detected using the mouse anti-
human MBL mAb, HYB-131-01 (Antibody Shop,
Copenhagen, Denmark), followed by alkaline phos-
phatase-conjugated goat anti-mouse IgG (Sigma-
Aldrich) and the colorimetric substrate p-nitrophenyl
phosphate (also from Sigma-Aldrich). The MBL
concentration was calculated from a standard curve
performed with each assay.
Statistical analysis was performed using SPSS v11.1
and STATAv8. Following assessment of normality of the
data, descriptive statistics were expressed as the mean
and standard deviation (SD) for normally distributedEur J Vasc Endovasc Surg Vol 31, 3 2006data and by median value and inter-quartile range (IQR)
for non-normally distributed data. MBL values were
normally distributed, and expressed using the mean
and standard error (SE) of the mean. Analysis of the
changes in MBL levels within patients were performed
using paired t-tests. A comparison of MBL levels
between groups after reperfusion was made on the
percentage change in levels from induction (to take into
account differences between subjects at induction)
using an (unpaired) t-test.Results
Twenty-three patients undergoing AAA repair and
eight controls were recruited. The patient demo-
graphics are given in Table 1. The operative details
are given in Table 2. All AAA patients underwent
open, transperitoneal repair of AAA using a midline
incision. All patients had infrarenal aortic clamp
placement. 14 (61%) of patients received a straight
aortic graft, with the remained receiving bifurcated
aorto-iliac grafts.
At induction of anaesthesia, the mean plasma MBL
concentration was 3240 ng/ml (SE 510 ng/ml) in AAA
patients, and 3600 ng/ml (SE 1100 ng/ml) in the
controls (pZ0.77 Student’s t-test, 95% CI for the
difference K2335 to 3056). During AAA repair,
patients demonstrated a steady decrease in plasma
MBL reaching a mean minimum level of 1956 ng/ml
(SE 397 ng/ml) after 30 min of reperfusion (p!0.01
paired t-test, 95% CI for the difference 776–1811). In
comparison to AAA patients, controls also experi-
enced a slight decrease in their MBL levels, but this
was not significant (pZ0.07 paired t-test, 95% CI for
the difference K84 to 747) (Fig. 1).
To account for the fact that patients displayed a
relatively large range of preoperative MBL levels, we
also calculated the degree to which the MBL levels
Table 2. Operative and postoperative data for all AAA subjects and
controls
AAA patients
(nZ23)
Controls (nZ8)
Operation time (min) 162 (53) 271 (156)
Clamp time (min) 49 (12) N/A
Straight graft 14 (61%) N/A
Blood loss (ml)* 1000 (800–1600) 135 (100–500)
Blood transfusion (units) 2.17 (2.23) 1.0 (1.41)
Fluid replacement (l)* 5.5 (4.5–6.0) 5.5 (3.8–7.4)
POSSUM score† 36.26 (5.67) 31.0 (4.63)
ITU/HDU stay (days)* 1.0 (1.0–3.0) 1.0 (0.25–2.75)
Hospital stay (days)* 9.0 (8.0–12.0) 9.5 (9.0–19.25)
Mortality 1 (4.3%) 0 (0%)
* Results are displayed as the mean value (SD) unless the data is
non-parametric, whereby the median value (IQR) is given.
† POSSUM score (post operative surgical score for the enumeration
of mortality) as described by Copeland et al.20
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Fig. 2. Mean percentage (%) change (and standard error) in
MBL levels for AAA (nZ23) and control (nZ8) subjects at
each stage of the procedure. Starting values for MBL are
100%, with relative decreases thereafter. For control subjects,
the corresponding reperfusion value is 2 h after the start of
the procedure.
MBL Consumption During AAA Repair 241changed in each individual patient. This was achieved
by dividing the pre-clamp, ischaemia and reperfusion
values by the induction value, and hence displaying
the values as the percentage change from baseline.
Fig. 2 clearly demonstrates how MBL levels decrease
during the procedure. AAA patients on average
experienced a 41% (SE 4.5%) decrease in their MBL
levels, whereas controls only experienced a 17% (SE
5.6%) decrease in MBL levels—a difference of 24%.
This difference in the percentage change in MBL levels
between AAA and control patients was statistically
significant (pZ0.003, 95% CI for the difference 9.5–
40%, Student’s t-test). There were no differences in
MBL levels between patients that had received a
bifurcated graft rather than a straight graft.
Mortality was 0% in the control group and 4.3%
(nZ1) in the AAA group. The cause of death was
multiple organ failure. This patient did not demon-
strate exceptional changes in MBL levels.0
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Fig. 1. Mean (standard error) change in systemic MBL levels
(ng/ml) for AAA and control subjects at each stage of the
procedure. For control subjects, the second blood sample
was taken 2 h after the start of the procedure. This
corresponds chronologically with the reperfusion value in
the AAA group.Discussion
This is the first study to demonstrate consumption of
MBL during elective, open repair of AAA. The
complement system plays an essential role in IRI, and
inhibition of complement activation reduces tissue
damage in experimental models of myocardial ischae-
mia. Prior to the discovery of the lectin pathway, these
effects were attributed to the classical pathway (mainly
because cleavage of complement C4 was observed).12
However, recent evidence indicates that it is the lectin
pathway that mediates tissue damage in IRI. For
example, in an in vitro study of endothelial cell
oxidative stress, it was shown that MBL binds to
ischaemic human endothelial cells (HUVECs) and that
this binding can be inhibited by monoclonal antibodies
against MBL14. Jordan et al. demonstrated that the
administration of such antibodies also leads to a
significant reduction in tissue injury in an in vivo
model of myocardial infarction in rats15. Moreover, it
has been shown that C1q deficient mice (i.e. mice
deficient of the classical pathway) are not protected
from complement mediated tissue damage in exper-
imental models of gastrointestinal or myocardial
ischemia,16,17 whereas MBL deficient mice are
protected.18
In a previous study monitoring complement
activation in blood samples from subjects undergoing
repair of thoraco-abdominal aortic aneurysm (TAAA)
and using AAA subjects as controls, Fiane et al.
observed downstream complement activation
products (C4bc, C3bBbP and C5-9) in 16 MBL-
sufficient TAAA patients, and in two MBL-deficient
patients that had received plasma during surgery, butEur J Vasc Endovasc Surg Vol 31, 3 2006
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plasma.19 The authors therefore concluded that MBL-
mediated complement activation is responsible for the
generation of downstream complement activation
products during TAAA repair. In contrast to our
results, Fiane and co-workers did not observe a
consumption of MBL during the course of surgery.
The precise reason for this is unclear, but may be a
reflection of ELISA technique (whether plasma or
serum was used for the ELISA was not specified), data
analysis, operation time (this was not specified) or
sample size (only five AAA patients were used, two of
which were MBL deficient).
Our data clearly demonstrate a significant drop in
MBL levels in all 23 patients during AAA. The slight
decrease in MBL levels observed between time points
1 and 2 (after induction of anaesthesia and just prior to
aortic clamping) cannot be accounted for by IRI, but it
was of a similar magnitude to the total decrease seen in
the controls, and is therefore likely to be a consequence
of the surgical procedure per se. The consumption of
MBL between time points 2 and 4 was highly
significant, and is indicative of MBL deposition,
presumably on the damaged endothelium. These
findings add to a growing body of evidence that
supports an important role for the lectin pathway in
IRI. Further studies would be useful however using
regional blood sampling techniques (as used in
previous studies21–23) to attempt to elicit the origin of
this inflammatory response. An older control group
would ideally also be used to address the age
difference between AAA patients and controls in this
study.
In light of the well established contribution of
complement activation to the pathology of reperfusion
injury, and the rapidly accumulating evidence that the
lectin pathway is activated on ischaemic endothelial
cells, we suggest that a transient inhibition of lectin
pathway activity could be a potential therapeutic
target to improve outcomes in patients undergoing
AAA surgery. Furthermore, transient inhibition of
lectin pathway activity could have a significant
therapeutic impact on the outcome of other diseases
or procedures that involve a transient ischaemic insult,
i.e. myocardial infarction, gut infarction, burns,
transplantation and stroke.Acknowledgements
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